Alzamend Neuro Inc

ALZN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.94

+$0.05 (+2.65%)

At close: Sep 21, 2026, 4:00 PM ET

$1.93

-$0.01 (-0.52%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q1 2027 Jul 30, 2026	Q4 2026 Apr 29, 2026	Q3 2026 Jan 30, 2026	Q2 2026 Oct 30, 2025	Q1 2026 Jul 30, 2025	Q4 2025 Apr 29, 2025	Q3 2025 Jan 30, 2025	Q2 2025 Oct 30, 2024	Q1 2025 Jul 30, 2024	Q4 2024 Apr 29, 2024	Q3 2024 Jan 30, 2024	Q2 2024 Oct 30, 2023	Q1 2024 Jul 30, 2023	Q4 2023 Apr 29, 2023	Q3 2023 Jan 30, 2023	Q2 2023 Oct 30, 2022	Q1 2023 Jul 30, 2022	Q4 2022 Apr 29, 2022	Q3 2022 Jan 30, 2022	Q2 2022 Oct 30, 2021	Q1 2022 Jul 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	55.37K	27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-55.37K	-27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-9.09M	-8.77M	-7.03M	-5.87M	-6.23M	-4.5M	-4.21M	-5.83M	-7.37M	-9.94M	-12.39M	-15.16M	-15.36M	-14.87M	-15.44M	-12.57M	-13.05M	-12.32M	-9.67M	-8.23M	-5.94M
Interest Income	1.48K	1.08K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-9.1M	-8.77M	-7.04M	-5.88M	-6.24M	-4.51M	-4.23M	-5.85M	-7.39M	-9.95M	-12.4M	-15.16M	-15.37M	-14.88M	-15.44M	-12.59M	-13.08M	-12.36M	-9.75M	-8.3M	-6.05M
Net Income	-9.1M	-8.77M	-7.04M	-5.88M	-6.24M	-4.51M	-4.23M	-5.85M	-7.39M	-9.95M	-12.4M	-15.16M	-15.37M	-14.88M	-15.44M	-12.59M	-13.08M	-12.36M	-9.75M	-8.3M	-6.05M
Selling & General & Admin	6.12M	5.14M	3.39M	3.06M	3.29M	3.08M	3.06M	3.22M	3.08M	3.48M	4.47M	6.26M	6.92M	7.42M	7.98M	7.13M	7.39M	7.12M	5.83M	5.03M	4.02M
Research & Development	2.97M	3.63M	3.65M	2.81M	2.95M	1.41M	1.15M	2.61M	4.3M	6.46M	7.92M	8.9M	8.44M	7.45M	7.46M	5.44M	5.66M	5.2M	3.83M	3.19M	1.92M
Other Expenses	-55.37K	-27.69K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.04M	8.74M	7.03M	5.87M	6.23M	4.5M	4.21M	5.83M	7.37M	9.94M	12.39M	15.16M	15.36M	14.87M	15.44M	12.57M	13.05M	12.32M	9.67M	8.23M	5.94M
Interest Expense	-11.11K	-6.62K	6.98K	7.66K	8.51K	18.03K	18.99K	19.45K	20.27K	10.1K	9.15K	8.73K	8K	7.7K	7.78K	22.02K	34.43K	46.52K	82.78K	132.12K	172.28K
Selling & Marketing Expenses	-150K	n/a	203.3K	153.3K	457.3K	347.3K	344K	344K	40K	247.33K	494.67K	742K	989.34K	742.6K	495.27K	247.93K	1.2K	600	600	600	n/a
Cost & Expenses	9.09M	8.77M	7.03M	5.87M	6.23M	4.5M	4.21M	5.83M	7.37M	9.94M	12.39M	15.16M	15.36M	14.87M	15.44M	12.57M	13.05M	12.32M	9.67M	8.23M	5.94M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.48M	3.34M	3.8M	3.38M	2.11M	468K	613K	377K	85K	76K	78K	72K	72K	71K	72K	72K	72K	65K	69K	69K	62K
Shares Outstanding (Diluted)	4.48M	3.34M	3.8M	3.38M	2.11M	711.27K	613.09K	392.41K	85.31K	76.46K	78.38K	72.93K	72.92K	71.69K	72.83K	72.21K	72.21K	65.13K	69.75K	69.23K	62.66K
EPS (Basic)	-2.30	-2.90	-4.59	-5.71	-9.02	-19.16	-27.87	-60.14	-96.38	-133.34	-168.31	-208.83	-212.05	-205.73	-219.03	-181.43	-190.36	-185.32	-148.90	-132.91	-106.21
EPS (Diluted)	-2.30	-2.90	-4.59	-5.71	-9.02	-19.16	-27.87	-60.14	-96.38	-133.34	-168.31	-208.83	-212.05	-205.73	-219.03	-181.43	-190.36	-185.32	-148.90	-132.91	-106.21
EBITDA	-9.12M	-8.77M	-6.94M	-5.79M	-6.17M	-4.45M	-4.16M	-5.78M	-7.32M	-9.89M	-12.35M	-15.12M	-15.33M	-14.85M	-15.41M	-12.55M	-11.75M	-11.03M	-8.39M	-6.88M	-5.88M
EBIT	-9.09M	-8.77M	-7.03M	-5.87M	-6.23M	-4.5M	-4.21M	-5.83M	-7.37M	-9.94M	-12.39M	-15.16M	-15.36M	-14.87M	-15.43M	-12.57M	-13.04M	-12.32M	-9.67M	-8.16M	-5.88M
Depreciation & Amortization	n/a	n/a	95.74K	80.74K	65.74K	50.74K	50.74K	50.74K	50.74K	50.74K	43.38K	36.02K	28.65K	23.07K	21.29K	15.97K	1.29M	1.28M	1.28M	1.28M	n/a